» Articles » PMID: 19734566

Characterization of Metabolic Interrelationships and in Silico Phenotyping of Lipoprotein Particles Using Self-organizing Maps

Overview
Journal J Lipid Res
Publisher Elsevier
Specialty Biochemistry
Date 2009 Sep 8
PMID 19734566
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma lipid concentrations cannot properly account for the complex interactions prevailing in lipoprotein (patho)physiology. Sequential ultracentrifugation (UCF) is the gold standard for physical lipoprotein isolations allowing for subsequent analyses of the molecular composition of the particles. Due to labor and cost issues, however, the UCF-based isolations are usually done only for VLDL, LDL, and HDL fractions; sometimes with the addition of intermediate density lipoprotein (IDL) particles and the fractionation of HDL into HDL(2) and HDL(3) (as done here; n = 302). We demonstrate via these data, with the lipoprotein lipid concentration and composition information combined, that the self-organizing map (SOM) analysis reveals a novel data-driven in silico phenotyping of lipoprotein metabolism beyond the experimentally available classifications. The SOM-based findings are biologically consistent with several well-known metabolic characteristics and also explain some apparent contradictions. The novelty is the inherent emergence of complex lipoprotein associations; e.g., the metabolic subgrouping of the associations between plasma LDL cholesterol concentrations and the structural subtypes of LDL particles. Importantly, lipoprotein concentrations cannot pinpoint lipoprotein phenotypes. It would generally be beneficial to computationally enhance the UCF-based lipoprotein data as illustrated here. Particularly, the compositional variations within the lipoprotein particles appear to be a fundamental issue with metabolic and clinical corollaries.

Citing Articles

EpiMetal: an open-source graphical web browser tool for easy statistical analyses in epidemiology and metabolomics.

Ekholm J, Ohukainen P, Kangas A, Kettunen J, Wang Q, Karsikas M Int J Epidemiol. 2020; 49(4):1075-1081.

PMID: 31943015 PMC: 7660139. DOI: 10.1093/ije/dyz244.


Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.

Paavola T, Kuusisto S, Jauhiainen M, Kakko S, Kangas-Kontio T, Metso J PLoS One. 2017; 12(2):e0171993.

PMID: 28207870 PMC: 5313225. DOI: 10.1371/journal.pone.0171993.


Use of self-organizing maps for analyzing the behavior of canines displaced towards midline under interceptive treatment.

Gandia-Aguilo V, Cibrian R, Soria E, Serrano A, Aguilo L, Paredes V Med Oral Patol Oral Cir Bucal. 2017; 22(2):e233-e241.

PMID: 28160587 PMC: 5359714. DOI: 10.4317/medoral.21509.


Statistical HOmogeneous Cluster SpectroscopY (SHOCSY): an optimized statistical approach for clustering of ¹H NMR spectral data to reduce interference and enhance robust biomarkers selection.

Zou X, Holmes E, Nicholson J, Loo R Anal Chem. 2014; 86(11):5308-15.

PMID: 24773160 PMC: 4110102. DOI: 10.1021/ac500161k.


A family based tailored counselling to increase non-exercise physical activity in adults with a sedentary job and physical activity in their young children: design and methods of a year-long randomized controlled trial.

Finni T, Saakslahti A, Laukkanen A, Pesola A, Sipila S BMC Public Health. 2011; 11:944.

PMID: 22185647 PMC: 3271995. DOI: 10.1186/1471-2458-11-944.

References
1.
Kang H, Gutin B, Barbeau P, Litaker M, Allison J, Le N . Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord. 2002; 26(8):1030-5. DOI: 10.1038/sj.ijo.0802045. View

2.
Parhofer K, Barrett P . Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. J Lipid Res. 2006; 47(8):1620-30. DOI: 10.1194/jlr.R600013-JLR200. View

3.
Jiang X, Bruce C, Mar J, Lin M, Ji Y, Francone O . Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest. 1999; 103(6):907-14. PMC: 408146. DOI: 10.1172/JCI5578. View

4.
Stein J, McBride P . Should advanced lipoprotein testing be used in clinical practice?. Nat Clin Pract Cardiovasc Med. 2006; 3(12):640-1. DOI: 10.1038/ncpcardio0719. View

5.
Nikkila J, Toronen P, Kaski S, Venna J, Castren E, Wong G . Analysis and visualization of gene expression data using self-organizing maps. Neural Netw. 2002; 15(8-9):953-66. DOI: 10.1016/s0893-6080(02)00070-9. View